ClinicalTrials.gg
Active, not recruitingNCT06511414Updated Nov 12, 2026

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure

An interventional study of duramesh and Control in Incisional Hernia and Ileostomy - Stoma, sponsored by Northwestern University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jan 2024, registered Jul 2024).
Updated Nov 12, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Incisional Hernia with a site in United States — 6 open to participants now, 8 under way, none of them phase 3. Incisional Hernia · United States.

Planned enrollment
10th of 20
106 · median 98
Started
2024
with 2 others
No phase
17 of 34
5 open now
Registered
30th of 34
by date

Among the 34 studies in Incisional Hernia with a site in United States, this one is the 10th largest by planned enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2024, is one of 17 with no phase, and was the 30th registered.

Incisional Hernia

212 studies on the registry are indexed under Incisional Hernia; 58 are open to participants now.

Browse Incisional Hernia studies →

Open to participants now

6 of the 34 studies in Incisional Hernia with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 39 Incisional Hernia studies recruiting now, 28 (72%) set no upper age limit and 2 (5%) stop at 75 or younger; 1 takes children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Incisional Hernia with a site in United States, or all of them as a file.
02

Study summary

Diverting ileostomy is frequently utilized to protect high-risk anastomoses, though it is not shown to reduce the leak rate it may reduce the severe consequences of an anastomotic leak. Ileostomy will be reversed with restoration of continuity in majority of patients. Stoma site incisional hernias after ileostomy closure are complex hernias that can be associated with abdominal pain, discomfort, and a diminished quality of life. Duramesh™ non-absorbable polypropylene suture is a hollow core, microporous, cylindrical suture made off in polypropylene filaments that are loosely braided and bonded to each other with heat and pressure. The Aim of this study is to evaluate Duramesh™ suture vs standard closure on rates of hernia formation after ileostomy closure.

03

Conditions studied

  • Incisional Hernia
  • Ileostomy - Stoma

Browse trials for

Keywords

  • duramesh,
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Patients undergoing ileostomy closure after surgery for cancer All patients with a stoma (independent of diagnosis)

      • Age 18 or greater
      • Surgical oncology patient where routine radiologic surveillance for is planned
      • Patient accepts participation and gives

Exclusion criteria

Exclusion Criteria:

    • Pregnancy

      • Prior mesh hernia repair at laparotomy site
      • less than 1 years
      • Patient is unable / unwilling to provide
      • Patient is unable to comply with the protocol or proposed follow-up visits
      • Patient is enrolled in another hernia study
      • Non-English-speaking participants
      • Data from children will not analyzed in this study.
      • Cognitively Impaired Adults: Data from cognitively impaired adults will not analyzed in this study.
      • Adults Unable to Consent: Data from adults unable to consent will not analyzed in this study.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
106 participants (estimated)

Study arms

  • Experimental
    Duramesh

    using duramesh suture for ileostomy fascial closure

    Device: duramesh

  • Active comparator
    Control

    standard ileostomy fascial closure

    Device: Control

Interventions

  • Deviceduramesh

    Duramesh™ non-absorbable polypropylene suture is a hollow core, microporous, cylindrical suture made off in polypropylene filaments that are loosely braided and bonded to each other with heat and pressure

  • DeviceControl

    standard closure of fascia

06

What researchers measure

Primary outcomes

  1. hernia rates

    Compare hernia rates after ileostomy closure between Duramesh™ and standard monofilament closure

    Time frame: 1 year

Secondary outcomes

  1. infection rate

    Evaluate potential side effects including infections and need for re intervention associated with Duramesh™ vs standard closure

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Dec 2026, 34 months after the start.

Of 60 non-industry interventional studies with no phase under Incisional Hernia, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 29 and three quarters within 60. This study's planned 34 months is below that.

Counting every sponsor, half of 67 studies reached it within 43 months; a quarter within 29 and three quarters within 60.

Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2024
First posted
Jul 22, 2024
StartActual
Jan 3, 2024
Primary completionEst.
Dec 1, 2026was Aug 2026
CompletionEst.
Dec 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 1, 2026→Dec 1, 2026
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Aug 1, 2026→Dec 1, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06511414
Responsible party
Vitaliy Poylin (Director, Section of Colon and Rectal Surgery, Northwestern University) — Principal investigator
First posted
Jul 22, 2024
Start date
Jan 3, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion